Inogen
INGN
INGN
228 hedge funds and large institutions have $2.59B invested in Inogen in 2018 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 73 increasing their positions, 83 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
228
Holders Change
+8
Holders Change %
+3.64%
% of All Funds
5.23%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
31
Increased
73
Reduced
83
Closed
21
Calls
$4.58M
Puts
$9.17M
Net Calls
-$4.58M
Net Calls Change
-$4.07M
Top Buyers
| 1 |
BlackRock
New York
|
+$13.7M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$10.4M |
| 3 |
Renaissance Technologies
New York
|
+$7.34M |
| 4 |
Goldman Sachs
New York
|
+$5.96M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.86M |
Top Sellers
| 1 |
William Blair & Company
Chicago,
Illinois
|
-$22.4M |
| 2 |
Millennium Management
New York
|
-$16.7M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$11.1M |
| 4 |
Bank of New York Mellon
New York
|
-$9.46M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.32M |
